SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-050944
Filing Date
2018-08-09
Accepted
2018-08-09 16:16:41
Documents
67
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-14093_110q.htm 10-Q 1273287
2 EX-31.1 a18-14093_1ex31d1.htm EX-31.1 12600
3 EX-31.2 a18-14093_1ex31d2.htm EX-31.2 12609
4 EX-32.1 a18-14093_1ex32d1.htm EX-32.1 5419
5 EX-32.2 a18-14093_1ex32d2.htm EX-32.2 5432
  Complete submission text file 0001104659-18-050944.txt   5960545

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stml-20180630.xml EX-101.INS 1429974
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20180630.xsd EX-101.SCH 47958
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20180630_cal.xml EX-101.CAL 47833
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20180630_def.xml EX-101.DEF 149158
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20180630_lab.xml EX-101.LAB 432990
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20180630_pre.xml EX-101.PRE 291738
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 181005242
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences